tetanus toxoid


Also found in: Dictionary, Thesaurus, Medical, Acronyms.

tetanus toxoid

[′tet·ən·əs ′täk‚sȯid]
(immunology)
Detoxified tetanus toxin used to produce active immunity against tetanus.
References in periodicals archive ?
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose.
Both Tdap vaccines showed that immune responses to diphtheria and tetanus toxoids were noninferior to responses produced by Td.
Adolescents aged 11-18 years who have completed the recommended childhood diphtheria and tetanus toxoids and pertussis vaccine (DTP)/DTaP vaccination series should receive a single dose of Tdap instead of tetanus and diphtheria toxoids (Td) vaccine, preferably at a preventive care visit at age 11 or 12 years (1).
Each dose of DTaP-IPV/Hib contains the same diphtheria and tetanus toxoids and pertussis antigens (inactivated pertussis toxin [PT], filamentous hemagglutinin [FHA], pertactin, and fimbriae types 2 and 3) as the FDA-licensed DTaP vaccine Daptacel (Sanofi Pasteur, Toronto, Canada) but contains an increased amount of inactivated PT and FHA (2).
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.
Two or more properly timed doses of Tetanus toxoid immunization given to pregnant woman or woman of child bearing age will reduce Neonatal Tetanus mortality by 94%.
A tetanus toxoid vaccine was given to women of reproductive age during the March and October 2014 tetanus immunization campaign of Kenya's Ministry of Health.
Other examples of cocooning include tetanus toxoid vaccination during pregnancy (two doses during the first pregnancy and one dose during other pregnancies), recommended in countries where tetanus is endemic to protect newborns from tetanus; and trivalent influenza vaccine administered during pregnancy.
The working group described the safety data on two Tdap doses as "reassuring," noting that the tetanus toxoid vaccine has not been associated with an excess risk of adverse events.
The most recent changes are the interim recommendations from the February 2011 ACIP meeting pertaining to tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine immunization and postexposure prophylaxis (PEP) for health care personnel.